Stage 2 · industry

Stage 2 Stocks in Hospitals & Diagnostic Centres

13 NSE Hospitals & Diagnostic Centres stocks are in a confirmed uptrend — Stage 2, Weinstein's advancing phase, where price trends above a rising 30-week moving average (bullish, trending). Ranked by setup score, end-of-day 2026-08-28.

Open full screener →

NSE Hospitals & Diagnostic Centres stocks in Stage 2 (uptrend), ranked by setup score, end-of-day 2026-08-28.
Stock	Close	1D	Setup	Weeks in stage
VIJAYA Vijaya Diagnostic Centre Ltd	₹1,452.5	-1.35%	7.9	16
YATHARTH Yatharth Hospital & Trauma Care Services Ltd	₹967.4	-0.58%	7.0	17
LALPATHLAB Dr. Lal PathLabs Ltd	₹1,931.1	-0.27%	6.9	12
HCG Healthcare Global Enterprises Ltd	₹696.3	-0.52%	6.3	6
MEDANTA Global Health Ltd	₹1,472.2	-2.43%	6.1	10
THYROCARE Thyrocare Technologies Ltd	₹584.35	+0.50%	5.7	13
METROPOLIS Metropolis Healthcare Ltd	₹588.45	+2.00%	5.2	13
APOLLOHOSP Apollo Hospitals Enterprise Ltd	₹8,838.5	+0.44%	5.2	20
KIMS Krishna Institute of Medical Sciences Ltd	₹771	+0.33%	4.8	13
ASTERDM Aster DM Healthcare Ltd	₹748.4	-0.85%	4.4	20
RAINBOW Rainbow Children's Medicare Ltd	₹1,442.8	+0.12%	4.4	11
GPTHEALTH GPT Healthcare Ltd	₹151.72	+0.22%	4.0	12
MAXHEALTH Max Healthcare Institute Ltd	₹1,014.1	+0.51%	3.5	6

Stage 2 in other sectors & industries

Browse the NSE stocks in a confirmed uptrend — Stage 2, Weinstein’s advancing phase — grouped by sector and industry, ranked by setup score.